Journal: Molecular therapy. Nucleic acids
Article Title: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.
doi: 10.1016/j.omtn.2021.06.005
Figure Lengend Snippet: Figure 3. FTO acts as m6A demethylase in pancreatic cell lines (A and B) Quantitative real-time PCR and WB assays showed reduced FTO levels in five PC cell lines. The mRNA and protein levels of FTO were (C and E) significantly reduced in SW1990 cells after small interfering (si)RNAs (siFTO-1, siFTO-2, and siFTO-3) transfection, whereas were (D and F) significantly increased in BxPC-3 cells after transfection with wild-type FTO (FTO-WT) and mutant FTO (FTO-mut) overexpressing plasmids. (G) FTO knockdown significantly upregulated the m6A level in total RNA of SW1990 cells. (H) FTO-WT overexpression significantly decreased the m6A level in total RNA of BXPC-3 cells. No significant changes were observed in the m6A levels upon FTO-mut overexpression. GAPDH was used as internal control in the quantitative real-time PCR and WB assays. NC, negative control. (A–H) *p < 0.05; **p < 0.01; ***p < 0.001; ns, no statistical significance by unpaired Student’s t test.
Article Snippet: CT A Cell lines, reagents, and culture conditions Human pancreatic cancer cell lines SW1990 (American Type Culture Collection [ATCC] CRL-2172), AsPC-1 (ATCCCRL-1682), PANC-1 (ATCC CRL-1469), BxPC-3 (ATCC CRL-1687), and Capan-2 (ATCC HTB-80) were purchased from ATCC (Manassas, VA, USA).
Techniques: Real-time Polymerase Chain Reaction, Transfection, Mutagenesis, Knockdown, Over Expression, Control, Negative Control